Organization · Venture Capital
Flying L Partners
Flying L Partners is a venture capital firm focused on the ophthalmic sector, investing in high-performance companies to drive innovation and value creation. They have been active since 2016, primarily in the United States.
Overview
What Flying L Partners does
What Flying L Partners is
Flying L Partners is a venture capital firm focused on the ophthalmic sector, investing in high-performance companies to drive innovation and value creation. They have been active since 2016, primarily in the United States.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2016
- Approximate age
- About 10 years
- Structured capabilities
- Funder
- Last reviewed
- March 27, 2026
Official channels
Find Flying L Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Flying L Partners as a funder
Investment thesis
Flying L Partners focuses on the ophthalmic sector, leveraging deep industry expertise to identify and invest in promising opportunities, while actively engaging with portfolio companies to drive innovation.
Focus narrative
Flying L Partners specializes in investments within the ophthalmic sector, focusing on medical devices and pharmaceuticals. The firm aims to raise capital for identified opportunities and actively collaborates with its portfolio companies to enhance innovation and market impact.
Value beyond capital
Flying L Partners adds value to its portfolio companies through active engagement, leveraging extensive industry knowledge and connections to accelerate growth and innovation in the ophthalmic sector.
Terms and economics
- Typical check
- $25,000,000
Focus and fit
- Stages
- Series A · Series B · Series C · Series D · Series E · Series F · Growth Equity
- Sectors
- Healthcare · Biotech · Medical Devices
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Glaukos, RxSight, IntraLase, LenSx, Oculeve, and Oyster Point Pharma, plus 1 more
Portfolio context
Notable portfolio companies include: RxSight: A leader in adjustable intraocular lens technology, nearing a $2B valuation. CorneaGen: A prominent provider of cornea transplants. AcuFocus: Known for its IC-8 intraocular lens for cataract patients. Surface Pharmaceuticals: Focused on biopharmaceuticals for ocular diseases. TearClear: Specializes in ophthalmic topical medication delivery.
Common questions
What to know about Flying L Partners
Upseed classifies Flying L Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.